ALPINE IMMUNE SCIENCES, INC. Deferred Offering Costs
ALPINE IMMUNE SCIENCES, INC. had Deferred Offering Costs of $0 as of 2022-12-31, per its 10-K filed 2023-03-23.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2023-03-23
- 2022-12-31: Deferred Offering Costs $0.00.
- 2022-09-30: Deferred Offering Costs $0.00.
- 2022-06-30: Deferred Offering Costs $487.00K.
- 2022-03-31: Deferred Offering Costs $362.00K.
| Period end | Deferred Offering Costs |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-23 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $487.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $362.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $352.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $291.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $281.00K 10-Q · filed 2021-08-10 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-17 |
| 2019-12-31 | $15.00K 10-K · filed 2020-03-30 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 |
| 2018-12-31 | $477.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | $307.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $285.00K 10-Q · filed 2018-08-09 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-18 |